Last edition
News about "CEE markets"
GENESIS Pharma Secures Exclusive Rights to Commercialise Donidalorsen Across 14 CEE Markets
GENESIS Pharma, a regional biopharma company specialising in the commercialisation of innovative medicines in Central and Eastern Europe (CEE), has entered into an exclusive agreement with Otsuka Pharmaceutical Europe Ltd., the European arm of Otsuka Pharmaceutical Co., Ltd., for the distribution and commercialisation of donidalorsen.
CEE Markets | 16/12/2025 | By Darshana
Er-Kim Partners with CNX Therapeutics to Distribute Oncology Products Across CEE and Turkey
Istanbul-based Er-Kim, an international pharmaceutical company specialising in the commercialisation of novel therapies, has entered into a distribution agreement with UK-based CNX Therapeutics to supply selected oncology products across Central and Eastern Europe (CEE) and Turkey.
CEE Markets | 26/08/2025 | By Dineshwori | 101
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy